This page contains brief information about isatuximab-irfc and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Isatuximab-irfc is approved to treat:
- Multiple myeloma. It is used in combination with pomalidomide and dexamethasone to treat adults who have already received at least two therapies, including lenalidomide and a proteasome inhibitor.
Isatuximab-irfc is also being studied in the treatment of other types of cancer.
More About Isatuximab-irfc
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Isatuximab-irfc - Check for trials from NCI's list of cancer clinical trials now accepting patients.